We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
PUT
Align Technology
ALGN
$12.1B
| $656K | ﹤0.01% |
4,200
-2,500
| -37% | -$358K |
|
|
SEG
2102
Seaport Entertainment Group
SEG
$372M
| $655K | ﹤0.01% |
+33,154
| New | +$743K |
|
|
SQNS
2103
Sequans Communications SA
SQNS
$44.2M
| $653K | ﹤0.01% |
145,424
+34,231
| +31% | +$229K |
|
2104
STAG Industrial
STAG
$7.11B
| $653K | ﹤0.01% |
17,762
-17,442
| -50% | -$662K |
|
|
LPRO
2105
DELISTED
Open Lending Corp
LPRO
| $652K | ﹤0.01% |
420,955
-83,045
| -16% | -$147K |
|
2106
Zimmer Biomet
ZBH
$18.2B
| $651K | ﹤0.01% |
7,245
-294,725
| -98% | -$27.9M |
|
2107
Jack in the Box
JACK
$350M
| $651K | ﹤0.01% |
34,339
-709,802
| -95% | -$12.8M |
|
2108
Amcor
AMCR
$21.5B
| $651K | ﹤0.01% |
15,601
-248,734
| -94% | -$10.3M |
|
2109
Avantis US Small Cap Value ETF
AVUV
$30.8B
| $650K | ﹤0.01% |
+6,371
| New | +$637K |
|
2110
Anavex Life Sciences
AVXL
$324M
| $649K | ﹤0.01% |
182,190
| – | – |
|
2111
Globe Life
GL
$14B
| $648K | ﹤0.01% |
4,635
-12,831
| -73% | -$1.74M |
|
2112
Integer Holdings
ITGR
$4.25B
| $645K | ﹤0.01% |
+8,224
| New | +$655K |
|
|
TECX
2113
Tectonic Therapeutic
TECX
$666M
| $645K | ﹤0.01% |
30,918
+5,842
| +23% | +$109K |
|
2114
Accel Entertainment
ACEL
$992M
| $645K | ﹤0.01% |
56,487
-76,008
| -57% | -$800K |
|
2115
Barings BDC
BBDC
$966M
| $643K | ﹤0.01% |
70,081
-62,696
| -47% | -$555K |
|
|
STLN
2116
Starling Oncology, Inc. Common Stock
STLN
$616M
| $642K | ﹤0.01% |
180,300
+155,136
| +616% | +$575K |
|
2117
Oportun Financial
OPRT
$343M
| $640K | ﹤0.01% |
121,011
-270,414
| -69% | -$1.43M |
|
2118
Viper Energy
VNOM
$15.4B
| $639K | ﹤0.01% |
16,553
-322,449
| -95% | -$12.2M |
|
2119
Edgewell Personal Care
EPC
$1.3B
| $639K | ﹤0.01% |
+37,496
| New | +$693K |
|
2120
RBB Bancorp
RBB
$459M
| $635K | ﹤0.01% |
30,778
+7,575
| +33% | +$149K |
|
2121
Outset Medical
OM
$89.1M
| $634K | ﹤0.01% |
170,758
-248,360
| -59% | -$2.13M |
|
2122
iRhythm Holdings
IRTC
$4.02B
| $632K | ﹤0.01% |
3,564
+2,301
| +182% | +$408K |
|
2123
iShares US Consumer Discretionary ETF
IYC
$1.21B
| $632K | ﹤0.01% |
6,126
+1,199
| +24% | +$123K |
|
2124
Corbus Pharmaceuticals
CRBP
$189M
| $631K | ﹤0.01% |
77,546
-24,963
| -24% | -$308K |
|
2125
Analog Devices
ADI
$190B
| $629K | ﹤0.01% |
2,319
-290,081
| -99% | -$72.9M |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.